Ranbaxy Laboratories Q2 net up 191.64% to Rs.291.15 Crores

Ranbaxy Laboratories Ltd has announced the following unaudited results for the quarter ended June 30, 2007.

The Company has posted a profit after tax of Rs 2911.50 million for the quarter ended June 30, 2007 as compared to Rs 998.30 million for the quarter ended June 30, 2006. Total Income (net of excise) has increased from Rs 10837.80 million for the quarter ended June 30, 2006 to Rs 10880.00 million for the quarter ended June 30, 2007.

The Consolidated results (as per Indian GAAP) are as follows: The Group has posted a profit after tax & minority Interests of Rs 2635.00 million for the quarter ended June 30, 2007 as compared to Rs 1211.00 million for the quarter ended June 30, 2006. Total Income (net of excise) has increased from Rs 14713.00 million for the quarter ended June 30, 2006 to Rs 16890.00 million for the quarter ended June 30, 2007.

The stock was trading at Rs.352.50, up by Rs.5.65 or 1.63%. The stock hit an intraday high of Rs.355.85 and low of Rs.346. The total traded quantity was 875111 compared to 2 week average of 467954.

Source : Equity Bulls

Keywords